...Paul Glare; Richard Chye; Mark Bloch; Mark Arya; Andrew Moore; John Montgomery Introduction: The aim was to demonstrate the safety and tolerability of cannabidiol (CBD) with Δ9-THC in patients with moderate to severe chronic back or neck pain unresponsive to over-the-counter non-opioid analgesics...

...Stefan Lorenzl; Franz Gottwald; Angelika Nistler; Laura Brehm; Renate Grötsch; Georg Haber; Christian Bremm; Christiane Weck; Carina Trummer; Werner Brand Introduction: A phase I, open-label clinical trial in healthy male subjects was conducted to assess the pharmacokinetic and safety profile...

..., and safety of this new “miracle cure.” As a result, CBD is under scrutiny on many levels, ranging from national health organizations and agricultural lobbyists to the WHO and FDA. The central question is whether CBD is simply a food supplement, an investigational new medicine, or even a narcotic...